Anzu Partners is an investment firm that focuses on breakthrough industrial and life sciences technology companies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations.
Anzu manages approximately $350 million in capital commitments, across two venture funds and a revenue-based investing (“RBI”) fund. The venture capital funds focus on investments in early-stage companies, ranging from pre-revenue to post-commercialization, primarily in the US and Canada with selective investments in Europe and Asia Pacific. RBI provides capital through a non-dilutive preferred share vehicle to post-revenue companies, offering an alternative to traditional venture and debt financing, that supports post-revenue companies across North America, Europe, and Asia Pacific.
We have a robust team of investment, technical, and operational professionals to drive results for our portfolio companies and investors. Anzu’s principals have 60+ years of combined experience as global investors and consultants, and have built a commercial support network spanning key industrial markets across the globe.
We focus on four key areas:
Robotics and Advanced Tools
Bioprocessing for Therapeutics
Synthetic Biology and Biomolecular Assembly
Nanomaterials and Electronic Materials
Biomaterials and Organic Materials
High Value New Consumables
Novel Fabrication Methods
Measurement & Monitoring
Microelectromechanical Systems Sensing
New Process Control and Automation Needs
Molecular Diagnostics & Characterization
Edge Computing and IoT
Computer-Aided Engineering Simulation
Artificial Intelligence and Data Analytics
Electronic Design Automation
Quantum and Computational Chemistry